These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. An autoantibody with potent antithrombin activity whose action could be inhibited by toluidine blue or methylene blue. Shojania AM; Meilleur G; Alvi AW Am J Hematol; 1987 Feb; 24(2):207-14. PubMed ID: 3812468 [TBL] [Abstract][Full Text] [Related]
26. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant. Exner T; Low J Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290 [TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery. Kim YS; Murkin JM; Adams SJ Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695 [TBL] [Abstract][Full Text] [Related]
28. Effect of aprotinin on activated clotting time, whole blood and plasma heparin measurements. Despotis GJ; Joist JH; Joiner-Maier D; Alsoufiev AL; Triantafillou AN; Goodnough LT; Santoro SA; Lappas DG Ann Thorac Surg; 1995 Jan; 59(1):106-11. PubMed ID: 7529483 [TBL] [Abstract][Full Text] [Related]
29. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo. Li DW; Lee IS; Sim JS; Toida T; Linhardt RJ; Kim YS Thromb Res; 2004; 113(1):67-73. PubMed ID: 15081567 [TBL] [Abstract][Full Text] [Related]
30. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood. Carr ME; Angchaisuksiri P; Carr SL; Martin EJ Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016 [TBL] [Abstract][Full Text] [Related]
31. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies. Pengo V; Biasiolo A; Rampazzo P; Brocco T Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002 [TBL] [Abstract][Full Text] [Related]
32. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery. Zaidan JR; Johnson S; Brynes R; Monroe S; Guffin AV Anesth Analg; 1986 Apr; 65(4):377-80. PubMed ID: 3954111 [TBL] [Abstract][Full Text] [Related]
33. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin]. Shevchenko LV; Ovchinnikova LK; Zolotukhin SI Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373 [TBL] [Abstract][Full Text] [Related]
34. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate. Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496 [TBL] [Abstract][Full Text] [Related]
35. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density. Poon MC; Hurst RE; Rives MS Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237 [TBL] [Abstract][Full Text] [Related]
36. Preparation and anticoagulation activity of sodium cellulose sulfate. Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735 [TBL] [Abstract][Full Text] [Related]
37. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test). McPherson J; Soberano ME; Macdonald C; Zucker MB Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885 [TBL] [Abstract][Full Text] [Related]
38. Heparin-like anticoagulant associated with plasma cell myeloma. Chapman GS; George CB; Danley DL Am J Clin Pathol; 1985 Jun; 83(6):764-6. PubMed ID: 3923825 [TBL] [Abstract][Full Text] [Related]
39. Heparin-like anticoagulant associated with systemic candidiasis. Horne MK; Chao ES; Wilson OJ Am J Hematol; 1990 Sep; 35(1):37-42. PubMed ID: 2389767 [TBL] [Abstract][Full Text] [Related]
40. Isolation of a heparin-like anticoagulant from the plasma of a patient with metastatic bladder carcinoma. Tefferi A; Owen BA; Nichols WL; Witzig TE; Owen WG Blood; 1989 Jul; 74(1):252-4. PubMed ID: 2752113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]